Should we screen for risk of type 1 diabetes?

Diabetes Care

Volumn 31, Issue 3, 2008, Pages 622-623

  Knip, Mikael ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE;

BODY MASS; DIABETIC KETOACIDOSIS; DISEASE PREDISPOSITION; EDITORIAL; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; MASS SCREENING; NOTE;

DIABETES MELLITUS, TYPE 1; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 44449099286     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0023     Document Type: Editorial

References (15)

1. Wilson JMG, Jungner G: Principles and practice of screening for disease. Geneva, World Health Organization (Public Health Paper No. 34), 1968
2. Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M: Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27: 1399-1404, 2004
3. Komulainen J, Lounamaa R, Knip M, Kaprio EA, Åkerblom HK, the Childhood Diabetes in Finland Study Group: Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual β-cell function. Arch Dis Child 75:410-415, 1996
4. Bonfanti R, Bazzigaluppi E, Calori G, Riva MC, Viscardi M, Bognetti E, Meschi F, Bosi E, Chiumello G, Bonifacio E: Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with type 1 diabetes mellitus. Diabet Med 15:844-850, 1998
5. Sosenko J, Krischer J, Palmer J, Mahon J, Cowie C, Greenbaum C, Cuthbertson D, LachinJ, Skyler J, the Diabetes Prevention Trial-Type 1 Study Group: A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 31:528-533, 2008
6. Wilkin TJ: The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44:914-922, 2001
7. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC: Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667, 2004
8. Mrena S, Virtanen S, Laippala P, Kulmala P, Hannila M-L, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 29:662-667, 2006
9. Lorenzen T, Pociot F, Hougaard P, Nerup J: Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 37:321-327, 1994
10. Siljander H, Veijola R, Reunanen A, Virtanen SM, Åkerblom HK, Knip M: Predic-Btion of type 1 diabetes among siblings of affected children and in the general population. Diabetologia 50:2272-2275, 2007
11. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population-based study. J Clin invest 101:327-336, 1998
12. Galatzer A, Green E, Ofan R, Benzaquen H, Yosefsberg Z, Weintrob N, Karp M, Vardi P: Psychological impact of islet cell antibody screening. J Pediatr Endocrinol Metab 14 (Suppl. 1):675-679, 2001
13. Bennett Johnson S, Tercyak KP Jr: Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care 18:1370-1372, 1995
14. IlonenJ, Reijonen H, Herva E, Sjöroos M, Iitiä A, Lövgren T, Veijola R, Knip M, Åkerblom HK, the Childhood Diabetes in Finland Study Group: Rapid HLA-DQB1 genotyping for four alleles in the assessment of diabetes risk in the Finnish population. Diabetes Care 19:795-800, 1996
15. Kimpimäki T, Kupila A, Hämäläinen A-M, Kukko M, Kulmala P, Savola K, Simell T, Muona P, Ilonen J, Simell O, Knip M: The first signs of β-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 86:4782-4788, 2001